Collexis Holdings, Inc. Acquires SyynX Solutions GmbH, Expands Application Portfolio
- Details
- Category: Business

CIBA Vision announces settlement of patent litigation with CooperVision, Inc.
- Details
- Category: Business
CIBA Vision, the eye care unit of Novartis, has reached a final global patent litigation settlement agreement with CooperVision, Inc. (NYSE: COO) that resolves all current patent infringement lawsuits between the two companies. CIBA Vision has licensed its so called "Nicolson" patents to CooperVision. This will enable both companies to move forward in bringing forth new and improved innovations to meet the needs of eye care professionals and consumers.
GlaxoSmithKline to acquire Reliant Pharmaceuticals
- Details
- Category: GlaxoSmithKline

Novartis withdraws its application to extend the marketing authorisation for Zometa
- Details
- Category: Novartis

Nycomed significantly increases profitability
- Details
- Category: Nycomed

Celgene to Acquire Pharmion for $2.9 Billion in Cash and Stock
- Details
- Category: Financial
Celgene Corporation (Nasdaq: CELG) and Pharmion Corporation (Nasdaq: PHRM) jointly announced the signing of a definitive merger agreement pursuant to which Celgene has agreed to acquire Pharmion. Under the terms of the merger agreement, Celgene will acquire all of the outstanding shares of Pharmion common stock for $72.00 per share payable in a combination of cash and shares of Celgene common stock. The transaction is expected to be slightly dilutive to earnings in 2008 and accretive in 2009 and beyond.
Menveo(TM) (MenACWY-CRM) vaccine to demonstrate an excellent immune response in infants
- Details
- Category: Novartis

More Pharma News ...
- Pfizer to Acquire Coley Pharmaceutical Group
- Abbott Partners With Operation Smile to Support 40 Medical Missions in 25 Countries
- Award recognises and rewards journalism that extends public awareness and understanding of COPD
- Roche signs licensing and settlement agreements for Hepatitis C immunodiagnostics
- Novo Nordisk celebrates first ever UN-observed World Diabetes Day
- Novel agent for treatment of Parkinson's disease in clinical development
- New Phase III Trial Results for Rivaroxaban